Mah Sing Healthcare gets nod to market gloves in US


MahSing Group Bhd founder and group managing director Tan Sri Leong Hoy Kum (right) receiving a box of rubber gloves from an employee at the group’s glove manufacturing factory in Kapar, Klang. - File pic/The Star

PETALING JAYA: Mah Sing Group Bhd’s unit has received the green light by the United States Food and Drug Administration (FDA) to market nitrile examination gloves in the US market.

The property developer, which diversified into glove manufacturing this year, said its healthcare business unit, Mah Sing Healthcare Sdn Bhd, received the 510(K) pre-market notification clearances from the FDA on Dec 4.

The Star Festive Promo: Get 35% OFF Digital Access

Monthly Plan

RM 13.90/month

Best Value

Annual Plan

RM 12.33/month

RM 8.02/month

Billed as RM 96.20 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Mah Sing Healthcare , sell , gloves , US ,

Next In Business News

Jinhua – a trading hub without borders
Up in Arms - or up the value chain?
Asia bonds for diversification
Singapore’s financial sector a big winner
Watts from water
AI disruption fears rock markets
Smart city can’t beat the traffic
Private equity hits a sixer
Dubai luxe property keeps booming
US LNG exporters lead in gas use

Others Also Read